LSL Pharma Group Inc. (TSXV:LSL)
0.3750
0.00 (0.00%)
At close: Dec 5, 2025
LSL Pharma Group Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | - | 0.3 | 0.01 | - | 0.74 | 1.93 | Upgrade
|
| Cash & Short-Term Investments | - | 0.3 | 0.01 | - | 0.74 | 1.93 | Upgrade
|
| Cash Growth | - | 3600.00% | - | - | -61.52% | 316.66% | Upgrade
|
| Accounts Receivable | - | 4.8 | 2.55 | 0.97 | 1.12 | 2.22 | Upgrade
|
| Other Receivables | - | 0.15 | 0.13 | 0.07 | 0.22 | 0.19 | Upgrade
|
| Receivables | - | 4.96 | 2.68 | 1.04 | 1.33 | 2.4 | Upgrade
|
| Inventory | - | 9.12 | 4.11 | 2.96 | 4.17 | 2.13 | Upgrade
|
| Prepaid Expenses | - | 1.01 | 0.41 | 0.21 | 0.13 | 0.05 | Upgrade
|
| Other Current Assets | 20.66 | - | - | 0.19 | 0.11 | - | Upgrade
|
| Total Current Assets | 20.66 | 15.38 | 7.2 | 4.4 | 6.48 | 6.51 | Upgrade
|
| Property, Plant & Equipment | 24.83 | 22.94 | 14.75 | 13.92 | 12.89 | 10.3 | Upgrade
|
| Goodwill | - | 0.16 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 14.33 | 13.27 | 8.93 | 8.98 | 9.39 | 9.81 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.22 | - | - | - | 0.1 | Upgrade
|
| Other Long-Term Assets | 0.38 | 1.54 | 0.02 | 0.02 | 0.28 | 0.46 | Upgrade
|
| Total Assets | 60.19 | 53.51 | 30.9 | 27.31 | 29.03 | 27.18 | Upgrade
|
| Accounts Payable | - | 4.5 | 4.92 | 4.54 | 2.54 | 2.47 | Upgrade
|
| Accrued Expenses | - | 0.69 | 1.06 | 1.58 | 1.17 | 1.64 | Upgrade
|
| Short-Term Debt | 6.34 | 2.56 | 3.77 | 2.91 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 1.45 | 5.22 | 1.58 | 1.89 | 6.03 | Upgrade
|
| Current Portion of Leases | - | 0.45 | 0.12 | 0.14 | 0.19 | 0.24 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.01 | - | 0.51 | Upgrade
|
| Other Current Liabilities | 7.2 | - | - | 0.87 | 1.46 | 1.66 | Upgrade
|
| Total Current Liabilities | 13.54 | 9.65 | 15.07 | 11.62 | 7.25 | 12.55 | Upgrade
|
| Long-Term Debt | 15.26 | 12.75 | 4.73 | 7.84 | 7.98 | 3.36 | Upgrade
|
| Long-Term Leases | - | 4.43 | 2.44 | 2.56 | 2.69 | 0.94 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 1.79 | - | - | - | - | Upgrade
|
| Total Liabilities | 34.81 | 28.62 | 22.25 | 22.02 | 17.92 | 16.84 | Upgrade
|
| Common Stock | 25.38 | 36.39 | 24.2 | 15.05 | 12.81 | 10.26 | Upgrade
|
| Additional Paid-In Capital | - | 3.05 | 2.32 | - | - | - | Upgrade
|
| Retained Earnings | - | -14.92 | -18.23 | -9.76 | -1.7 | 0.08 | Upgrade
|
| Comprehensive Income & Other | - | 0.38 | 0.38 | - | - | - | Upgrade
|
| Shareholders' Equity | 25.38 | 24.89 | 8.66 | 5.29 | 11.11 | 10.34 | Upgrade
|
| Total Liabilities & Equity | 60.19 | 53.51 | 30.9 | 27.31 | 29.03 | 27.18 | Upgrade
|
| Total Debt | 21.6 | 21.64 | 16.27 | 15.03 | 12.74 | 10.57 | Upgrade
|
| Net Cash (Debt) | -21.6 | -21.34 | -16.26 | -15.03 | -12 | -8.64 | Upgrade
|
| Net Cash Per Share | -0.19 | -0.20 | -0.20 | -0.23 | -0.20 | -0.16 | Upgrade
|
| Filing Date Shares Outstanding | 115.53 | 115.53 | 82.44 | 68.09 | 62.66 | 54.89 | Upgrade
|
| Total Common Shares Outstanding | 115.53 | 115.53 | 82.44 | 68.09 | 62.66 | 54.89 | Upgrade
|
| Working Capital | 7.12 | 5.72 | -7.87 | -7.22 | -0.78 | -6.04 | Upgrade
|
| Book Value Per Share | 0.22 | 0.22 | 0.10 | 0.08 | 0.18 | 0.19 | Upgrade
|
| Tangible Book Value | 11.05 | 11.46 | -0.28 | -3.69 | 1.72 | 0.54 | Upgrade
|
| Tangible Book Value Per Share | 0.10 | 0.10 | -0.00 | -0.05 | 0.03 | 0.01 | Upgrade
|
| Land | - | 0.56 | 0.28 | 0.28 | 0.28 | 0.28 | Upgrade
|
| Buildings | - | 5.61 | 3.97 | 3.91 | 3.63 | 3.51 | Upgrade
|
| Machinery | - | 11.41 | 6.02 | 5.55 | 5.33 | 4.73 | Upgrade
|
| Construction In Progress | - | - | - | 1.77 | 0.47 | - | Upgrade
|
| Leasehold Improvements | - | 3.99 | 3.71 | 0.93 | 0.93 | 0.82 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.